课题基金 / 基金详情

Cardiovascular Scientist Training Program

Cardiovascular Scientist Training Program
心血管科学家培训计划
批准号:
10653133
负责人:
KALYANAM SHIVKUMAR
金额:
$12.8万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-07-01 至 2024-06-30

项目摘要

项目成果

KALYANAM SHIVKUMAR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT The training program described in this renewal application represents a new paradigm for training academic cardiologists as cardiovascular scientists, based on the UCLA STAR (Specialty Training and Advanced Research) Program combining clinical subspecialty training with research training leading to a Ph.D. or Masters degree. This program has been in existence here at UCLA for 24 years and has trained over 44 cardiovascular scientists and researchers. M.D. trainees will complete 2 years of subspecialty cardiology training and 3-4 years of research training that fulfills the requirements for a Ph.D. degree in one of the basic sciences or Health Service Research/Outcomes/Policy, or a Masters of Clinical Research, including formal course work and research leading to successful thesis defense. M.D./Ph.D. trainees undergo 2 years of post- doctoral research training, including elective course work. Six positions are requested, to provide support for the research training component only. The training faculty consists of 35 senior preceptors and 11 supporting faculty. Only senior preceptors may serve as primary research mentors, and they come from 8 groups: the UCLA Cardiovascular Research Laboratory, the UCLA Atherosclerosis Research Unit, the UCLA Cellular & Molecular Cardiology Unit, the Broad Stem Cell Research Center, the UCLA ACCESS Program (a multi- departmental program administering Ph.D. training in life sciences), the School of Engineering, the Biomathematics Department and, for health services research, the UCLA School of Public Health and RAND Graduate School. Supporting faculty do not act as primary mentors, but play a key role in enhancing the overall research environment and fostering translational research from the basic to the clinical arena. The research programs of the faculty are supported by over 50 million dollars in direct costs annually from extramural sources. By integrating cardiology subspecialty training with the formal recruitment of Ph.D. training (or equivalent post-doctoral training for those already having a Ph.D.), the UCLA Cardiology STAR Program provides graduates with the rigorous research background essential to translate the unparalleled advances in molecular health sciences into modern molecular medicine.
期刊论文(87)
专著(0)
科研奖励(0)
会议论文
Risk factors for development of aminoglycoside resistance among gram-negative rods.
革兰氏阴性杆菌中出现氨基糖苷类耐药性的危险因素。
DOI: 10.1093/ajhp/zxz201
发表时间: 2019
期刊: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
影响因子: --
作者: [Richter,StefanE, Miller,Loren, Needleman,Jack, Uslan,DanielZ, Bell,Douglas, Watson,Karol, Humphries,Romney, McKinnell,JamesA]
通讯作者: McKinnell,JamesA
Relation of Patent Foramen Ovale to Acute Mountain Sickness.
卵圆孔未闭与急性高山病的关系。
DOI: 10.1016/j.amjcard.2019.03.030
发表时间: 2019
期刊: The American journal of cardiology
影响因子: --
作者: [West,BrianH, Fleming,RubineGevorgyan, AlHemyari,Bashar, Banankhah,Pooya, Meyer,Kenneth, Rozier,LeslieH, Murphy,LindaS, Coluzzi,AlexandraC, Rusheen,JoshuaL, Kumar,Preetham, Elashoff,David, Tobis,JonathanM]
通讯作者: Tobis,JonathanM
Reductive nitrosylation and S-nitrosation of hemoglobin in inhomogeneous nitric oxide solutions.
不均匀一氧化氮溶液中血红蛋白的还原亚硝基化和 S-亚硝基化。
DOI: 10.1016/j.niox.2004.03.003
发表时间: 2004
期刊: Nitric oxide : biology and chemistry
影响因子: --
作者: [Han,TaeH, Fukuto,JonM, Liao,JamesC]
通讯作者: Liao,JamesC
DOI: 10.1002/jbio.200810045
发表时间: 2008-12
期刊: JOURNAL OF BIOPHOTONICS
影响因子: 2.8
作者: [Schenke-Layland, Katja]
通讯作者: Schenke-Layland, Katja
48
    Cardiac Neuromodulation: Mechanisms and Therapeutics
    Administrative Core
    Neural Control of Myocardial Excitability at the Nerve Myocyte Interface
    CARDIAC NEUROMODULATION IN HUMANS: MECHANISMS & THERAPIES
    海外基金